Physician profile
Kristina N Waggoner
NPI 1225422231
$786.06
in general payments reported to CMS, 2019-2025
12 companies · $768 in 2025
The $768 reported for 2025 was more than what 79% of Gerontology (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $161).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $18.51 · 2025: $768.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $786.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $786.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $162.60 | 2025 | Repatha |
| Novartis Pharmaceuticals Corporation | $150.93 | 2025 | |
| Merck Sharp & Dohme LLC | $113.42 | 2025 | Verquvo, Capvaxive |
| Astrazeneca Pharmaceuticals Lp | $94.55 | 2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $71.22 | 2025 | Eliquis, Camzyos |
| Alnylam Pharmaceuticals INC. | $55.19 | 2025 | Amvuttra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.08 | 2024-2025 | Jardiance |
| Atricure, INC. | $28.67 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Novo Nordisk INC | $24.01 | 2025 | Wegovy |
| Esperion Therapeutics, INC. | $17.38 | 2025 | Nexletol |
| Inspire Medical Systems, INC. | $15.60 | 2025 | Inspire |
| Lilly USA, LLC | $15.41 | 2025 | Mounjaro, Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristina Waggoner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.